The patient is waiting
Below you can quickly e-mail or request materials from our investor relations department. If you prefer, you may call our toll-free number at 800.962.AGEN (2436).
10-K/Annual Report Agenus news and press releases Proxy statement (postal mail) Proxy statement (email)
We respect your privacy. All personal information you provide to us will be treated with the greatest confidentiality and will be used only to fulfill your request or respond to your inquiry. By submitting this form, you indicate that you are providing us with your information voluntarily. For more information, please read our complete privacy policy.